Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gleave

Showing results (351-360 of 941) with videos related to

Pageof 95
Sort By:
Cancer Research|July 4, 2003
Castration-induced increases in insulin-like growth factor-binding protein 2 promotes proliferation of androgen-independent human prostate LNCaP tumorsSatoshi Kiyama, Kevin Morrison, Tobias Zellweger, et al.
BMC Nephrology|September 22, 2016
Relationship of clusterin with renal inflammation and fibrosis after the recovery phase of ischemia-reperfusion injuryJia Guo, Qiunong Guan, Xiuheng Liu, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 27, 2017
Maximal testosterone suppression in the management of recurrent and metastatic prostate cancerLaurence Klotz, Rodney H Breau, Loretta L Collins, et al.
Molecular Endocrinology (Baltimore, Md.)|May 14, 2011
Consensus PP1 binding motifs regulate transcriptional corepression and alternative RNA splicing activities of the steroid receptor coregulators, p54nrb and PSFLiangliang Liu, Ning Xie, Paul Rennie, et al.
The Prostate|November 11, 2011
Carbidopa enhances antitumoral activity of bicalutamide on the androgen receptor-axis in castration-resistant prostate tumorsChristian Thomas, Latif A Wafa, Francois Lamoureux, et al.
Molecular Cancer Therapeutics|March 18, 2004
Nucleotide-based therapies targeting clusterin chemosensitize human lung adenocarcinoma cells both in vitro and in vivoLaura V July, Eliana Beraldi, Alan So, et al.
Oncotarget|October 6, 2017
Establishment of a neuroendocrine prostate cancer model driven by the RNA splicing factor SRRM4Yinan Li, Ruiqi Chen, Mary Bowden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2008
GLI2 knockdown using an antisense oligonucleotide induces apoptosis and chemosensitizes cells to paclitaxel in androgen-independent prostate cancerShintaro Narita, Alan So, Susan Ettinger, et al.
Journal of Chemical Information and Modeling|December 28, 2016
Cheminformatics Modeling of Adverse Drug Responses by Clinically Relevant Mutants of Human Androgen ReceptorNaman Paul, Lavinia A Carabet, Nada Lallous, et al.
Cancer Research|August 17, 2012
Clusterin mediates TGF-β-induced epithelial-mesenchymal transition and metastasis via Twist1 in prostate cancer cellsMasaki Shiota, Anousheh Zardan, Ario Takeuchi, et al.
Pageof 95

Showing results (351-360 of 941) with videos related to

Sort By:
Pageof 95
Cancer Research|July 4, 2003
Castration-induced increases in insulin-like growth factor-binding protein 2 promotes proliferation of androgen-independent human prostate LNCaP tumorsSatoshi Kiyama, Kevin Morrison, Tobias Zellweger, et al.
BMC Nephrology|September 22, 2016
Relationship of clusterin with renal inflammation and fibrosis after the recovery phase of ischemia-reperfusion injuryJia Guo, Qiunong Guan, Xiuheng Liu, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 27, 2017
Maximal testosterone suppression in the management of recurrent and metastatic prostate cancerLaurence Klotz, Rodney H Breau, Loretta L Collins, et al.
Molecular Endocrinology (Baltimore, Md.)|May 14, 2011
Consensus PP1 binding motifs regulate transcriptional corepression and alternative RNA splicing activities of the steroid receptor coregulators, p54nrb and PSFLiangliang Liu, Ning Xie, Paul Rennie, et al.
The Prostate|November 11, 2011
Carbidopa enhances antitumoral activity of bicalutamide on the androgen receptor-axis in castration-resistant prostate tumorsChristian Thomas, Latif A Wafa, Francois Lamoureux, et al.
Molecular Cancer Therapeutics|March 18, 2004
Nucleotide-based therapies targeting clusterin chemosensitize human lung adenocarcinoma cells both in vitro and in vivoLaura V July, Eliana Beraldi, Alan So, et al.
Oncotarget|October 6, 2017
Establishment of a neuroendocrine prostate cancer model driven by the RNA splicing factor SRRM4Yinan Li, Ruiqi Chen, Mary Bowden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2008
GLI2 knockdown using an antisense oligonucleotide induces apoptosis and chemosensitizes cells to paclitaxel in androgen-independent prostate cancerShintaro Narita, Alan So, Susan Ettinger, et al.
Journal of Chemical Information and Modeling|December 28, 2016
Cheminformatics Modeling of Adverse Drug Responses by Clinically Relevant Mutants of Human Androgen ReceptorNaman Paul, Lavinia A Carabet, Nada Lallous, et al.
Cancer Research|August 17, 2012
Clusterin mediates TGF-β-induced epithelial-mesenchymal transition and metastasis via Twist1 in prostate cancer cellsMasaki Shiota, Anousheh Zardan, Ario Takeuchi, et al.
Pageof 95